ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

Temozolomide: A General Review

Updated on May 12, 2016

Overview

Temozolomide is an oral prescription cancer drug indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme and refractory anaplastic astrocytoma, a form of brain cancer. Many of the available chemotherapeutic agents come in injectable formulation. However, there are other cancer drugs that comes in oral formulations such as tamoxifen, iressa, estramustine, etoposide as well as temozolomide. With respect to the purpose of the article, Temodar, another name for temozolomide, is also available in injectable formulations. This is a very beneficial advantage because patients who were discharged from hospitals can actually be issued an oral formulation.

Anaplastic Astrocytoma, a Brain Tumor

Source

Drug Kinetics

The drug undergoes a rapid conversion at a physiologic pH to active compound. In order words, temozolomide is not active directly. There are four basic ways in which the drug is controlled in the body. These include absorption, metabolism, distribution and elimination. The drug control processes are necessary information in order to determine appropriate dose in patients with reduced body organ function i.e. kidney failure. In this article, I will only address absorption and excretion.

Dosing and Administration

The two conditions for which temodar are prescribed are treated below with their corresponding dosage:

For newly diagnosed glioblastoma multiforme, administer 75mg/m2 for 42 days together with focal radiotherapy followed by initial maintenance dose of 150mg/m2 once daily forDays 1-5 of a 28 day cycle of temodar for 6 cycles.

For refractory anaplastic astrocytoma, the initial starting dose is 150mg/m2 once daily for 5 days per 28 day management cycle.

Glioblastoma Multiforme

Source

Drug Absorption

After oral administration, temozolomide is rapidly and completely absorbed with highest level occurring at 1 hour. Certain drugs are affected by food intake and this in turn, can affect the time of action of the drug. Unfortunately, temodar happened to be one of those types of drugs. In fact, food reduces the rate and extent of its absorption. A certain study found that oral capsule and intravenous form of the drug infused over 90 minutes have similar absorption rate. Therefore, the oral formulation is considered bioequivalent to the injection.

Excretion

It is essential that a drug undergoes excretion process in order to avoid toxicity. About 38% of administered temozolomide dose is recovered over 7 days. In, fact, the major route of excretion of the drug is via the kidneys. If an individual has kidney problem, then consideration is given in dosing the medication for appropriateness. The primary elimination pathway for the drug is by pH-dependent degradation to a carboxamide.

Intravenous Temodar Formulation

Source

Temodar Capsule

Side Effects

Some of the side effects attributed to the administration of temodar include headache, nausea, vomiting, and loss of appetite, constipation and weakness. Nausea and vomiting can sometimes be quite serious. Food and Drug Administration mandates that every manufacturer must continue to conduct post marketing surveillance to ensure public safety. Sometimes, the effects are managed when not serious since the risk of the tumor is higher. Therefore, one weighs benefit versus risk.

Conclusion

As new scientists continue to emerge, the world would continue to have answers to challenging medical dilemma. Brain tumor is not an easy scientific problem to address, but a very difficult and challenging one. I hope drug manufacturers specializing in oncology therapeutics would continue to advance the training in drug development. Temozolomide is a miracle drug for brain tumor due to its availability in oral and intravenous forms.

Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://hubpages.com/privacy-policy#gdpr

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)